Government’s attachment to ‘biopharmaceutical’ discouraging pharmaceutical field

As the government tightening the fostering policy for new growth engines, the pharmaceutical industry raise a voice that the industry cannot be dualistically categorized into pharmaceutical and biopharmaceutical.  

The industry argues even though they both are included in the single range of so-called ‘drugs’ – they are only divided into chemical and biological drugs depending on ingredients –...